Altered nitric oxide production mediates matrix-specific PAK2 and NF-?B activation by flow

Molecular Biology of the Cell

Volumn 24, Issue 3, 2013, Pages 398-408

  Yurdagul, Arif ^a   Chen, Jie ^a   Funk, Steven Daniel ^a   Albert, Patrick ^a   Kevil, Christopher G ^a,b   Orr, A Wayne ^a,b  

^a University of Colorado Anschutz Medical Campus   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; NCK PROTEIN; NITRIC OXIDE; P21 ACTIVATED KINASE 2;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; CELL MEMBRANE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SHEAR FLOW; SHEAR STRESS; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AORTA; ATHEROSCLEROSIS; BASEMENT MEMBRANE; BIOMECHANICS; CATTLE; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMANS; NF-KAPPA B; NITRIC OXIDE; P21-ACTIVATED KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 84873388580     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E12-07-0513     Document Type: Article

References (41)

1. Andrews AM, Jaron D, Buerk DG, Kirby PL, Barbee KA (2010). Direct, real-time measurement of shear stress-induced nitric oxide produced from endothelial cells in vitro. Nitric Oxide 23, 335-342.
2. Bokoch GM (2003). Biology of the p21-activated kinases. Annu Rev Biochem 72, 743-781.
3. Boo YC, Hwang J, Sykes M, Michell BJ, Kemp BE, Lum H, Jo H (2002a). Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A-dependent mechanism. Am J Physiol Heart Circ Physiol 283, H1819-H1828.
4. Boo YC, Sorescu G, Boyd N, Shiojima I, Walsh K, Du J, Jo H (2002b). Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A. J Biol Chem 277, 3388-3396.
5. Boo YC, Sorescu GP, Bauer PM, Fulton D, Kemp BE, Harrison DG, Sessa WC, Jo H (2003). Endothelial NO synthase phosphorylated at SER635 produces NO without requiring intracellular calcium increase. Free Radic Biol Med 35, 729-741.
6. Chen F, Lu Y, Castranova V, Rojanasakul Y, Miyahara K, Shizuta Y, Vallyathan V, Shi X, Demers LM (1999a). Nitric oxide inhibits HIV tat-induced NF-kappaB activation. Am J Pathol 155, 275-284.
7. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, Kemp BE (1999b). AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443, 285-289.
8. Chiang HY, Korshunov VA, Serour A, Shi F, Sottile J (2009). Fibronectin is an important regulator of flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol 29, 1074-1079.
9. Chiu JJ, Chien S (2012). Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev 91, 327-387.
10. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr., Shin WS, Liao JK (1995). Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96, 60-68.
11. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM (1999). Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601-605.
12. Dixit M, Loot AE, Mohamed A, Fisslthaler B, Boulanger CM, Ceacareanu B, Hassid A, Busse R, Fleming I (2005). Gab1, SHP2, and protein kinase A are crucial for the activation of the endothelial NO synthase by fluid shear stress. Circ Res 97, 1236-1244.
13. Fryer BH, Wang C, Vedantam S, Zhou GL, Jin S, Fletcher L, Simon MC, Field J (2006). cGMP-dependent protein kinase phosphorylates p21-activated kinase (Pak) 1, inhibiting Pak/Nck binding and stimulating Pak/vasodilator-stimulated phosphoprotein association. J Biol Chem 281, 11487-11495.
14. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC (1999). Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399, 597-601.
15. Funk SD, Yurdagul A, Green JM, Jhaveri KA, Schwartz MA, Orr AW (2010). Matrix-specific protein kinase A signaling regulates p21-activated kinase activation by flow in endothelial cells. Circ Res 106, 1394-1402.
16. González-Santiago L, López-Ongil S, Rodríguez-Puyol M, Rodríguez-Puyol D (2002). Decreased nitric oxide synthesis in human endothelial cells cultured on type I collagen. Circ Res 90, 539-545.
17. Grumbach IM, Chen W, Mertens SA, Harrison DG (2005). A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription. J Mol Cell Cardiol 39, 595-602.
18. Guo D, Tan YC, Wang D, Madhusoodanan KS, Zheng Y, Maack T, Zhang JJ, Huang XY (2007). A Rac-cGMP signaling pathway. Cell 128, 341-355.
19. Hahn C, Orr AW, Sanders JM, Jhaveri KA, Schwartz MA (2009). The subendothelial extracellular matrix modulates JNK activation by flow. Circ Res 104, 995-1002.
20. Hahn C, Schwartz MA (2009). Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol 10, 53-62.
21. Howe AK (2001). Cell adhesion regulates the interaction between Nck and p21-activated kinase. J Biol Chem 276, 14541-14544.
22. Howe AK, Juliano RL (2000). Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase. Nat Cell Biol 2, 593-600.
23. Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM (1996). Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA 93, 9114-9119.
24. Lu W, Katz S, Gupta R, Mayer BJ (1997). Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck. Curr Biol 7, 85-94.
25. Lu W, Mayer BJ (1999). Mechanism of activation of Pak1 kinase by membrane localization. Oncogene 18, 797-806.
26. Lutz SZ et al. (2011). Genetic ablation of cGMP-dependent protein kinase type I causes liver inflammation and fasting hyperglycemia. Diabetes 60, 1566-1576.
27. Matthews JR, Botting CH, Panico M, Morris HR, Hay RT (1996). Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res 24, 2236-2242.
28. Orr AW, Hahn C, Blackman BR, Schwartz MA (2008). p21-activated kinase signaling regulates oxidant-dependent NF-kappa B activation by flow. Circ Res 103, 671-679.
29. Orr AW, Pallero MA, Murphy-Ullrich JE (2002). Thrombospondin stimulates focal adhesion disassembly through Gi-and phosphoinositide 3-kinase-dependent ERK activation. J Biol Chem 277, 20453-20460.
30. Orr AW, Sanders JM, Bevard M, Coleman E, Sarembock IJ, Schwartz MA (2005). The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis. J Cell Biol 169, 191-202.
31. Orr AW, Stockton R, Simmers MB, Sanders JM, Sarembock IJ, Blackman BR, Schwartz MA (2007). Matrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis. J Cell Biol 176, 719-727.
32. Paulucci-Holthauzen AA, O'Connor KL (2006). Use of pseudosubstrate affinity to measure active protein kinase A. Anal Biochem 355, 175-182.
33. Rizzo NO, Maloney E, Pham M, Luttrell I, Wessells H, Tateya S, Daum G, Handa P, Schwartz MW, Kim F (2010). Reduced NO-cGMP signaling contributes to vascular inflammation and insulin resistance induced by high-fat feeding. Arterioscler Thromb Vasc Biol 30, 758-765.
34. Rohwedder I, Montanez E, Beckmann K, Bengtsson E, Duner P, Nilsson J, Soehnlein O, Fassler R (2012). Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation. EMBO Mol Med 4, 564-576.
35. Sawada N, Salomone S, Kim HH, Kwiatkowski DJ, Liao JK (2008). Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1. Circ Res 103, 360-368.
36. Spiecker M, Darius H, Kaboth K, Hubner F, Liao JK (1998). Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol 63, 732-739.
37. Umansky V, Hehner SP, Dumont A, Hofmann TG, Schirrmacher V, Droge W, Schmitz ML (1998). Co-stimulatory effect of nitric oxide on endothelial NF-kappaB implies a physiological self-amplifying mechanism. Eur J Immunol 28, 2276-2282.
38. Viji RI, Kumar VBS, Kiran MS, Sudhakaran PR (2009). Modulation of endothelial nitric oxide synthase by fibronectin. Mol and Cell Biochem 323, 91-100.
39. Zhan Q, Ge Q, Ohira T, Van Dyke T, Badwey JA (2003). p21-activated kinase 2 in neutrophils can be regulated by phosphorylation at multiple sites and by a variety of protein phosphatases. J Immunol 171, 3785-3792.
40. Zhao ZS, Manser E, Lim L (2000). Interaction between PAK and nck: a template for Nck targets and role of PAK autophosphorylation. Mol Cell Biol 20, 3906-3917.
41. Zhou G-L, Zhuo Y, King CC, Fryer BH, Bokoch GM, Field J (2003). Akt phosphorylation of serine 21 on Pak1 modulates Nck binding and cell migration. Mol Cell Biol 23, 8058-8069.